- Investing Ideas
- /
- U.S. Can They Turn the Tide
U.S. Can They Turn the Tide
UPDATED May 16, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
202 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
IVZ | US$16.09 | 5.8% | 5.0% | US$7.3b | US$16.70 | PS1.3x | E32.1% | 5.1% | Diversified Financials | ||
TFC | US$40.15 | 2.7% | 34.6% | US$53.8b | US$43.25 | PB1x | E70.6% | 5.2% | Banks | ||
ACAD | US$14.85 | -2.4% | -36.0% | US$2.5b | US$27.16 | PS3x | E40.8% | n/a | Pharmaceuticals & Biotech | ||
FLNC | US$18.24 | -2.7% | -18.8% | US$3.3b | US$29.20 | PS1.1x | E100.6% | n/a | Capital Goods | ||
BANC | US$14.09 | -5.8% | n/a | US$2.4b | US$16.84 | PB0.8x | E140.8% | 2.8% | Banks | ||
INSP | US$159.03 | -8.8% | -47.5% | US$4.7b | US$250.73 | PS7.1x | E52.9% | n/a | Healthcare | ||
RAMP | US$33.16 | 1.4% | 25.8% | US$2.2b | US$47.75 | PS3.4x | E176.3% | n/a | Software | ||
TEAM | US$182.21 | 1.3% | 23.0% | US$47.9b | US$240.61 | PS11.4x | E41.3% | n/a | Software | ||
SMAR | US$41.94 | 8.0% | -11.9% | US$5.7b | US$49.26 | PS6x | E51.0% | n/a | Software | ||
PTVE | US$13.45 | -0.07% | 79.6% | US$2.4b | US$16.36 | PB1.8x | E69.8% | 3.0% | Materials | ||
SYM | US$46.16 | 3.2% | 47.3% | US$27.2b | US$55.53 | PS3x | E128.1% | n/a | Capital Goods | ||
FIVN | US$53.87 | 0.6% | -11.4% | US$4.0b | US$83.36 | PS4.2x | E61.9% | n/a | Software | ||
GDRX | US$8.06 | 16.3% | 56.8% | US$2.7b | US$9.13 | PS4x | E43.1% | n/a | Healthcare | ||
AXSM | US$77.35 | 5.0% | 0.6% | US$3.6b | US$123.56 | PS14.6x | E65.1% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$19.10 | 10.1% | 87.4% | US$3.1b | US$26.42 | PS19x | E123.6% | n/a | Semiconductors | ||
SPB | US$93.35 | -1.3% | 30.3% | US$2.8b | US$104.25 | PB1.2x | E35.6% | 1.8% | Household | ||
GLBE | US$28.40 | -5.1% | -16.2% | US$4.9b | US$43.08 | PS8.3x | E88.9% | n/a | Retail | ||
MHK | US$120.87 | 1.0% | 22.7% | US$7.9b | US$128.21 | PB1x | E48.0% | n/a | Consumer Durables | ||
MRNA | US$132.64 | 8.1% | 5.8% | US$49.5b | US$138.51 | PS9.9x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
BGNE | US$171.03 | 1.4% | -25.2% | US$17.2b | US$267.01 | PS6.5x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
ITCI | US$66.53 | 1.5% | 5.6% | US$7.1b | US$90.60 | PS13.7x | E60.5% | n/a | Pharmaceuticals & Biotech | ||
AMED | US$94.95 | 0.4% | 24.2% | US$3.1b | US$97.78 | PS1.4x | E68.5% | n/a | Healthcare | ||
ADMA | US$9.06 | 30.7% | 124.3% | US$2.1b | US$10.50 | PS7.4x | E30.6% | n/a | Pharmaceuticals & Biotech | ||
MDGL | US$217.17 | 5.0% | -21.5% | US$4.5b | US$363.86 | PB5.4x | E64.3% | n/a | Pharmaceuticals & Biotech |